Study of an injection for overweight or obese adults
Part of Hormones & metabolism clinical trials.
This trial tests a new injection called SA030 to see if it can help with weight loss in people who are overweight or obese. It's an early-stage study, so the main goals are to check safety and how the body handles the drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- Your body mass index (BMI) is between 25 and 40.
- You are generally healthy, with minor health issues okay if the doctor agrees.
- If you are able to have children, you must agree to use highly effective birth control during the study.
- You have not used weight-loss medications, herbal supplements, or other products that affect weight in the last month.
- You have not had weight changes of more than 5% in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injected medicine (called HS-20136-2) to see if it is safe and how the body handles it. It is an early (phase 1) trial that includes healthy people and people with overweight, and the goal is to learn about possible effects on weight and metabolism.
This study tests a new injectable medication to help adults with obesity or overweight who don't have diabetes lose weight. It involves a reduced-calorie diet and exercise plan, and may offer an effective treatment option for weight management.
This study tests a new injection (MWN117) in healthy people and in people with obesity. It aims to see if the drug is safe and how the body handles it, which may eventually help with weight management.
This study tests an injected medication called ABBV-295 for adults with obesity. The goal is to see how safe it is and how the body processes it. You may join if you have a BMI between 30 and 45 and are generally healthy, and you haven't been on other weight loss treatments recently.
This study tests a new investigational injection called MWN110 in people who are overweight or have obesity. The goal is to see if the drug is safe and how it affects the body, which may help with weight management.
This study tests a new medicine, SRSD384, to see if it can help people who are overweight or obese lose weight. It is an early-stage trial, so the focus is on safety and how well the medicine works.
Hear when a new Obese trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.